Newsroom
Truveta news releases
A new era in cancer research: Truveta offers the most complete, representative, and timely real-world data on all cancers
BELLEVUE, Wash. – May 8, 2025 – Today, Truveta announced a new era in cancer research with more than 7 million oncology patient journeys spanning more than 100 cancer types, delivering an unprecedented breadth of regulatory grade data to support researchers in...
A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades
Published in the American Journal of Preventative Medicine, the new study shows that for the first time since its peak in 2022, syphilis incidence has declined, with larger decreases for men and young adults. BELLEVUE, WA — April 9, 2025 — A new study published in the...
New Truveta data and capabilities help researchers accelerate scientifically rigorous research
BELLEVUE, Wash. – March 26, 2025 – Today, Truveta announced that Truveta Data has expanded to include new administrative data to enable more comprehensive analyses of healthcare outcomes and patient journeys. The company also announced two new Truveta Studio...
Truveta Data expands beyond EHR data with linked closed claims for more than 200 million patients
Closed claims complete the longitudinal patient journey in Truveta Data, enabling regulatory grade safety and effectiveness studies, replacing clinical trials and registries BELLEVUE, Wash. – February 12, 2025 – Today, Truveta announced the expansion of Truveta Data...
New Truveta study highlights patterns of discontinuation and reinitiation of GLP-1 RA medications
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine at University of Pennsylvania BELLEVUE, Wash. – January 31, 2025 – Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor...
US health systems announce the Truveta Genome Project, creating the world’s largest and most diverse database to discover the science of humanity
The Regeneron Genetics Center® will sequence up to ten million exomes, helping to accelerate drug discovery and transform patient care BELLEVUE, Wash. – January 13, 2025 – Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford...
Truveta achieves HITRUST r2 Certification, demonstrating the highest level of information protection assurance
HITRUST r2 Certification demonstrates Truveta’s relentless commitment to the highest standards of security and privacy to protect regulatory-grade data. BELLEVUE, Wash. – November 20, 2024 – Truveta announced that its platform Truveta Studio and Truveta Data have...
Truveta Data, the most complete, timely, and clean electronic health record data, now includes more than 120 million de-identified patients
Researchers with more than 100 organizations use regulatory-grade Truveta Data to enable their scientifically rigorous research BELLEVUE, Wash. – November 14, 2024 –Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health...
Truveta Studio now includes Truveta Tru, a research assistant powered by generative AI
Trained on the Truveta Language Model and Truveta Data, the most complete and representative EHR data, Tru enables researchers to accelerate their research in Truveta Studio using simple, natural language BELLEVUE, Wash. – October 29, 2024 – Today, Truveta announced...
